is a debt instrument approved to be offered for sale in a debt issuance program by the regulators under (2) for each specific investor (tailor-made product); (c) any case other than (a) and (b), being
is a debt instrument approved to be offered for sale in a debt issuance program by the regulators under (2) for each specific investor (tailor-made product); (c) any case other than (a) and (b), being
"). The transaction size is equal to 1.31 percent of Net Tangible Asset (NTA) of the Company according to the consolidated financial statements of the Company for the 6-month period ending 30 June 2018
of consideration) Value of Transaction gained (Paid) x 100 = 133,583,482 x 100 Total assets of the Company (According to the latest financial statement, review by Certified Public accountant of the
Ref. No. IVL 007/05/2018 May 10, 2018 The President The Stock Exchange of Thailand Subject: Submission of Annual Audited Financial Statements and the Management Discussion and Analysis of Indorama
) Consolidated Financial Results: 4Q17 & FY2017 Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) 2 / 12 In 2017, CentralWorld and CentralPlaza Rama 3 have undergone major
Ref. No. IVL 005/11/2019 11 November 2019 The President The Stock Exchange of Thailand Subject: Submission of Quarterly Review of Financial Statements and the Management Discussion and Analysis of
securities lending 25% 5 total SIP 7 1 : (single entity limit) 15% : product limit 6 derivatives derivatives (hedging) 4 : (concentration limit) 1 ( ) 1.1 1 3 (financial liability) . ( P a g e 29 | ( ) KTFFE86
determination of record date and the date of 2020 Annual General Meeting of Shareholders) To: President The Stock Exchange of Thailand Attachment: 1. Financial assistance to KT Medical Service Company Limited 2
Exchange of Thailand Demeter Corporation Public Company Limited (“DCORP”) (“The Company”) would like to submit the reviewed financial statements for year 2017 ended December 31, 2017. Such financial